Evidence map›Paper›PMID 29265477›Full record

ReviewSeminars in dialysis2018

There's no place like home: 35-year patient survival on home hemodialysis.

Jerry Z Yu, Connie M Rhee, Antoney Ferrey, Alex Li, Anna Jin, Yongen Chang, Uttam Reddy, Wei Ling Lau, Jason Chou, Jula Inrig and 1 more

Open access · greenAbstract readCase ReportsReview
In one paragraph

Review in Seminars in dialysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Jerry Z YuDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Connie M RheeDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Antoney FerreySt Joseph's Medical Center, Orange, CA, USA.
Alex LiNorthwest Kidney Center, Snoqualmie, WA, USA.
Anna JinTibor Rubin Veterans Affairs Medical Center, Long Beach, CA, USA.
Yongen ChangDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Uttam ReddyDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Wei Ling LauDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Jason ChouDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Jula InrigDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
Kamyar Kalantar-ZadehDivision of Nephrology and Hypertension, University of California Irvine School of Medicine, Orange, CA, USA.
University of California, Irvine · USUniversity of California, Irvine Medical Center · USSt. Joseph Medical Center · USNorthwest Kidney Centers · USTibor Rubin VA Medical Center · US

Funding

MALNUTRITION, DIET AND RACIAL DISPARITIES IN CKDK24DK091419 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI KALANTAR-ZADEH, KAMYAR · 2011 to 2020
$1.8M
Hypothyroidism, Cardiovascular Health, and Survival in Kidney DiseaseK23DK102903 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI RHEE, CONNIE MEEYOUNG · 2014 to 2018
$955k
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis PatientsR03DK114642 · NIDDK · UNIVERSITY OF CALIFORNIA-IRVINE · PI RHEE, CONNIE MEEYOUNG · 2017 to 2018
$155k
NIDDK NIH HHS K23 DK102903NIDDK NIH HHS K24 DK091419NIDDK NIH HHS R03 DK114642
6 · The paper itself

Abstract

The vast majority of maintenance dialysis patients suffer from poor long-term survival rates and lower levels of health-related quality of life. However, home hemodialysis is a historically significant dialysis modality that has been associated with favorable outcomes as well as greater patient autonomy and control, yet only represents a small minority of the total dialysis performed in the United States. Some potential disadvantages of home hemodialysis include vascular access complications, infection-related hospitalizations, patient fatigue, and attrition. In addition, current barriers and challenges in expanding the utilization of this modality include limited patient and provider education and technical expertise. Here we report a 65-year old male with end-stage renal disease due to Alport's syndrome who has undergone 35 years of uninterrupted thrice-weekly home hemodialysis (ie, every Sunday, Tuesday, and Thursday evening, each session lasting 3 to 3¼ hours in length) using a conventional hemodialysis machine who has maintained a high functional status allowing him to work 6-8 hours per day. The patient has been able to liberalize his dietary and fluid intake while only requiring 3-4 liters of ultrafiltration per treatment, despite having absence of residual kidney function. Through this case of extraordinary longevity and outcomes after 35 years of dialysis and a review of the literature, we illustrate the history of home hemodialysis, its significant clinical and psychosocial advantages, as well as the barriers that hinder its widespread adaptation.

Indexed as

Quality of LifeAgedAsianDisease ProgressionHemodialysis, HomeHumansKidney Failure, ChronicMaleNephritis, HereditaryRisk AssessmentSurvivorsTreatment Outcome

Identifiers

PMID29265477
PMCPMC5935528
OpenAlexW2776202219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.